Entrada Therapeutics

TRDA

Entrada Therapeutics has been a target of short sellers for a while. The current short interest of 6.02% is slightly above the average of the last 12 months (3.31%).

Short Interest Trend

Share Price

Total NSP

6.02%

-0.06%

vs. last month

Also interesting? All insider buys at Entrada Therapeutics

Found an error? Questions? Ideas?